India Records Better Child Nutrition and Higher Institutional Births, National Survey Finds

Date:

Share post:

The Ministry of Health and Family Welfare has released the key findings of the Sixth Round of the National Family Health Survey (NFHS-6), 2023-24. Executed independently by the International Institute for Population Sciences (IIPS) across 679,238 households, NFHS-6 provides vital data to track India’s progress toward United Nations Sustainable Development Goals.

It was seen that the demographics & welfare rate of thepopulation aged 60+ grew to 12.9%. Health insurance coverage saw a massive surge, rising from 41.0% in NFHS-5 to 60.2%.The Total Fertility Rate stabilized at 2.0. Women marrying before the legal age of 18 dropped nationally to 20.1%.In maternal care it was seen , institutional deliveries reached 90.6%. However, Caesarean sections jumped to 27.2% nationally, soaring to 54.1% in private facilities. Full immunizationbin children rose to 82.6%. Child stunting dropped sharply from 35.5% to 29.3%Obesity rose to 30.7% for women and 27.3% for men, alongside a spike in high blood sugar levels. 

Divergent state trends emerged. Andhra Pradesh led in health insurance (91.9%) but faced high C-section rates (52.2%). Bihar showed remarkable nutritional recovery, cutting child stunting to 35.6%. Assam significantly reduced child marriage to 25.3%, while Arunachal Pradesh achieved 98.2% household electricity connectivity.

Union Health Minister Jagat Prakash Nadda noted that NFHS-6 will critically enable policymakers to formulate informed, corrective interventions at state and national levels.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...